Elsevier期刊
期刊
会议
图书
作者:Xinyan Li , Weichen Li , Lingping Hou
来源:[J].Value in Health Regional Issues, 2019, Vol.18, pp.1-7
摘要:ABSTRACT(#br)Background(#br)The first-line bevacizumab plus chemotherapy resulted in a clinical efficacy for Chinese patients with advanced nonsquamous non–small-cell lung cancer (NSCLC). Some economic analyses have carried out various methods to evaluate the cost-effectiven...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×